Xenglu Lin 25/5mg Tablet

Xenglu Lin 25/5mg Tablet – Maximum-Strength Empagliflozin + Linagliptin Dual Therapy for Type 2 Diabetes

  • Empagliflozin 25mg + Linagliptin 5mg high-strength combo
  • Maximum diabetes control + proven heart & kidney protection
In stock
9 People are viewing this right now
Sale price Rs.687.00 PKR
Add to Wishlist

Xenglu Lin 25/5mg Tablet

Xenglu Lin 25/5mg Tablet – Maximum-Strength Empagliflozin + Linagliptin Dual Therapy for Type 2 Diabetes

Rs.687.00

Xenglu Lin 25/5mg Tablet – High-Dose SGLT2 + DPP-4 Combo for Superior Glucose, Heart & Kidney Protection

Xenglu Lin 25/5mg Tablet combines the highest dose of empagliflozin 25mg (SGLT2 inhibitor) with linagliptin 5mg (DPP-4 inhibitor) in a single once-daily tablet. This powerful dual-action formula delivers exceptional A1C reduction, promotes greater weight loss, lowers blood pressure, and provides proven protection against heart failure, cardiovascular death, and diabetic kidney disease progression. Ideal for patients with established cardiovascular disease, chronic kidney disease, or those needing intensive glucose control beyond metformin or lower-dose therapies.

  • Maximum-dose empagliflozin for strongest glucose & cardio-renal benefits
  • Enhanced A1C reduction with dual complementary mechanisms
  • Greater weight loss & blood pressure improvement
  • Proven to reduce heart failure hospitalisation & CV mortality
  • Single convenient daily tablet

  1. Take one tablet once daily in the morning
  2. Swallow whole with water – can be taken with or without food
  3. Use alone or in combination with metformin, insulin, or other agents as prescribed
  4. Continue healthy diet, exercise, and regular blood glucose monitoring
  5. If a dose is missed, take it as soon as remembered unless it’s almost time for the next dose

Q1: Why choose 25/5mg over 10/5mg?
A1: The 25mg empagliflozin dose gives stronger sugar lowering, more weight loss, and greater heart/kidney protection.

Q2: How much weight can I expect to lose?
A2: Most patients lose 3–6 kg over several months due to calorie loss in urine.

Q3: How much does it lower A1C?
A3: Typically 1.5–2.0% reduction when added to existing therapy.

Q4: Is it safe if I already have heart disease?
A4: Yes – this exact combination is proven to reduce heart failure risk and major CV events.

Q5: Does it cause hypoglycemia?
A5: Very low risk when used alone or with metformin; slight increase if combined with insulin/sulfonylurea.

Empagliflozin, Linagliptin, Microcrystalline Cellulose, Lactose Monohydrate, Crospovidone, Magnesium Stearate, Hypromellose, Titanium Dioxide, Macrogol, Talc, Iron Oxide Yellow/Red

  • Use only under doctor supervision with regular kidney function and volume status checks
  • Maintain good hydration to prevent dehydration or urinary/genital infections
  • Stop immediately and seek medical help if ketoacidosis symptoms appear (nausea, vomiting, abdominal pain, extreme fatigue)
  • Not for type 1 diabetes or diabetic ketoacidosis
  • Contraindicated in severe renal impairment (eGFR <30 mL/min)
  • Discontinue at least 3–4 days before major surgery or serious illness

Recently viewed products